Predominance of delta variant among the COVID-19 vaccinated and unvaccinated individuals, India, May 2021

Published:August 05, 2021DOI:https://doi.org/10.1016/j.jinf.2021.08.006

      Highlights

      • Vaccine breakthrough SARS-CoV-2 infections were reported during COVID-19 second wave in India.
      • Prevalence of Delta (B.1.617.2) variant was not different between the vaccinated and unvaccinated groups.
      • Progression of COVID-19 cases to severe illness and mortality was lower in the vaccinated as compared to unvaccinated group.

      Keywords

      To read this article in full you will need to make a payment

      Subscribe:

      Subscribe to Journal of Infection
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sansone E.
        • Tiraboschi M.
        • Sala E.
        • Albini E.
        • Lombardo M.
        • Castelli F.
        • et al.
        Effectiveness of BNT162b2 vaccine against the B.1.1.7 variant of SARS-CoV-2 among healthcare workers in Brescia, Italy.
        J Infect. 2021; 83: e17-e18https://doi.org/10.1016/j.jinf.2021.04.038
      1. Ministry of Health and Family Welfare, Govt of India. Covid-19 vaccination. Frequently asked questions 2021. Available at https://www.mohfw.gov.in/covid_vaccination/vaccination/faqs.html#who-will-get-the-vaccine. Accessed on 11 August 2021

      2. Singh U.B., Rophina M., Chaudhry R., Vigneshwar S., Bala K., Bhoyar R.C., et al. Variants of concern responsible for SARS-CoV-2 vaccine breakthrough infections from India 2021. OSF Pre-print Available at https://doi.org/10.31219/osf.io/fgd4x

        • Rana K.
        • Mohindra R.
        • Pinnaka L.
        Vaccine breakthrough infections with SARS-CoV-2 variants.
        N Engl J Med. 2021; 385: e7https://doi.org/10.1056/NEJMc2107808
        • Prévost J.
        • Finzi A.
        The great escape? SARS-CoV-2 variants evading neutralizing responses.
        Cell Host Microbe. 2021; 29: 322-324https://doi.org/10.1016/j.chom.2021.02.010
      3. Ministry of Health and Family Welfare, Govt of India. Genome sequencing by INSACOG shows variants of concern and a Novel variant in India_24 MAR 2021 2021. Available at https://pib.gov.in/PressReleaseIframePage.aspx?PRID=1707177. Accessed on 11 August 2021

      4. Malani A., Ramachandran S., Tandel V., Parasa R., Sudharshini S., Prakash V. et al., SARS-CoV-2 seroprevalence in Tamil Nadu in October-November 2020. Available at MedRxiv2021:2021.02.03.21250949. 10.1101/2021.02.03.21250949, accessed on 11 August 2021

      5. State Control Room. Directorate of public health and preventive medicine health and family welfare department, government of Tamil Nadu, Media Bulletin 2021. Available at: https://stopcorona.tn.gov.in/wp-content/uploads/2020/03/Media-Bulletin-15-06-21-COVID-19.pdf, accessed on 11 August 2021

        • Bhoyar R.C.
        • Jain A.
        • Sehgal P.
        • Divakar M.K.
        • Sharma D.
        • Imran M.
        • et al.
        High throughput detection and genetic epidemiology of SARS-CoV-2 using COVIDSeq next-generation sequencing.
        PLoS One. 2021; 16e0247115https://doi.org/10.1371/journal.pone.0247115
      6. Dhar M.S., Marwal R., Radhakrishnan V.S., Ponnusamy K., Jolly B., Bhoyar R.C. et al., Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India. Available at: MedRxiv2021:2021.06.02.21258076.,10.1101/2021.06.02.21258076, accessed on 11 August 2021.

      7. Yadav P.D., Sapkal G.N., Ella R., Sahay R.R., Nyayanit D.A., Patil D.Y. et al., Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152. Available at: BioRxiv2021 :2021.06.05.447177. 10.1101/2021.06.05.447177, accessed on 11 August 2021.

      8. Planas D., Veyer D., Baidaliuk A., Staropoli I., Guivel-Benhassine F., Rajah Maaran M. et al., Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals. Available at: BioRxiv2021 :2021.05.26.445838. 10.1101/2021.05.26.445838, accessed on 11 August 2021.